DRREDDY vs VIYASH: Stock Comparison

Dr Reddys Laboratories Ltd vs Viyash Scientific Ltd

Live data: 27 July 2026, 4:08 PM IST • Source: NSE and company filings

Dr Reddys Laboratories Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a lower P/E, a higher ROE and a higher dividend yield, while Viyash Scientific Ltd shows faster revenue growth, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Dr Reddys Laboratories Ltd and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, DRREDDY is more favourable on 7 of 13 scored metrics and VIYASH on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DRREDDY is the larger company
₹96,171 Cr vs ₹11,330 Cr
P/E Ratio
DRREDDY has a lower P/E
29.85x vs 61.82x
P/B Ratio
DRREDDY has a lower P/B
2.54x vs 3.77x
EPS
DRREDDY has higher earnings per share
₹39.73 vs ₹4.06
Dividend Yield
DRREDDY has a higher dividend yield
0.69% vs 0%
Revenue Growth (TTM YoY)
VIYASH has faster revenue growth
0% vs -11.6%
EPS Growth (TTM YoY)
VIYASH has faster EPS growth
0% vs -86.2%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricDRREDDYVIYASH
Live Price₹1,150.8₹259.7
Day Change-0.08%3.51%
Volume10.53 L13.24 L
52-Week High₹1,414.9₹298
52-Week Low₹1,101₹178.13
Distance from 52W High-18.67%-12.85%

Valuation

MetricDRREDDYVIYASH
Market Cap₹96,171 Cr₹11,330 Cr
P/E Ratio29.85x61.82x
P/B Ratio2.54x3.77x
EPS₹39.73₹4.06
Book Value₹460.31₹66.6
Dividend Yield0.69%0%

Growth

MetricDRREDDYVIYASH
Revenue Growth (TTM YoY)-11.6%0%
EPS Growth (TTM YoY)-86.2%0%
Qtr Sales Growth-11.5%129%
Qtr Profit Growth-86.1%455%

Profitability & Leverage

MetricDRREDDYVIYASH
ROE11.2%11%
ROCE13%19%
Net Margin12.76%6.57%
Operating Margin19.2%19.1%
Debt to Equity0.2x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYVIYASH
Promoter Holding26.64% 0.01 pp0%
FII Holding32.07% 1.01 pp4.5% 1.56 pp
DII Holding31.74% 1.02 pp3.75% 4.24 pp
Public Holding9.35% 0.02 pp30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.